1．Guanglin Zhang, Peide Huang, Anan Chen, Weiyi He, Zhen Li, Ge Liu and Ju Wang(corresponding author). How BMP-2 induces EMT and breast cancer stemness through Rb and CD44? Cell Death & Disease(IF=5.9)
2．RONGYING SONG, DINGDING WANG, RONG ZENG and JU WANG(corresponding author). Synergistic effects of fibroblast growth factor-2 and bone morphogenetic protein-2 on bone induction. MOLECULAR MEDICINE REPORTS(IF=1.7). 16: 4483-4492, 2017
3．Peide Huang, Anan Chen, Weiyi He, Zhen Li, Guanglin Zhang, Zhong Liu, Ge Liu, Xueting Liu, Shuilian He, Gang Xiao,Feicheng Huang, Jan Stenvang, Nils Brünner, An Hong and Ju Wang(corresponding author). BMP-2 induces EMT and breast cancer stemness through Rb and CD44. Cell Death Discovery (2017) 3, 17039
4．Zhong Liu1,*, Ge Liu1,*, Guang-Lin Zhang1,*, Yan-Qing He2, Shu-Shu Zhang3,Yi Wang1, Wei-Yi He1, Guo-Hua Cheng4, Xue-Song Yang2, Jun Xu3, Ju Wang1,#.Binding of human recombinant mutant soluble ectodomain of FGFR2IIIc to c subtypeof FGFRs: Implications for anticancer activity. Oncotarget，2016.10.18，7(42)：68473-68488
5．Wang Ju※(first author，）, Yu Zhihong※, Zhou Zhiyou, Huang Hui, Wang Dingding, Sun Li，et al. Inhibition of α-SMA by Ectodomain of FGFR2c to Attenuate Lung Fibrosis. Molecular Medicine.2012, 2012, 18（6）：992 -1002(IF 5.91)（equal contribution）
6．Ju Wang※(first author，corresponding author）, Xue-ting Liu※, Hui Huang, Gang Xiao, Zhi-you Zhou, Yang Chen, Zhi-hong Yu, Shui-lian He, An-an Chen, Ding-ding Wang, ying He, Zhi-cheng Zhangand An Hong. Antitumor Activity of a Recombinant Soluble Ectodomain of Mutant Human Fibroblast Growth Factor Receptor-2 IIIc. Mol Cancer Ther 2011;10:1656-1666. (IF 5.2) （equal contribution）
7．Yu Zhi-hong, Wang Ding-ding, Zhou Zhi-you, He Shui-lian, Chen An-an, Wang Ju (corresponding author). Mutant soluble Ectodomain of FGFR2IIIc AttenuatesBleomycin-induced Pulmonary Fibrosis in Mice. Biol. Pharm. Bull. 2012, 35(5): 731–736.（IF1.8）